Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02455219 · ClinicalTrials.gov registry record
DatScan With Prototype Collimator
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 20
- Enrollment target
NCT02455219: Completed study, sponsored by University of Minnesota.
NCT02455219 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02455219 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
A collimator is an accessory to a SPECT/CT scanner. It can be compared to a camera lens or filter that enhances or improves photos. The prototype collimators are able to magnify target organs about four times compared to the current collimators. In this study we are validating a new collimator design, which will allow for quantitative measurement of dopamine receptors within the brain, not previously performed using a single photon gamma camera.
Interventions
- DEVICE Prototype UHRSZ (UltraHigh Resolution Smart Zoom) Collimator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-09 |
What the finished NCT02455219 record still lists
NCT02455219 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Prototype UHRSZ (UltraHigh Resolution Smart Zoom) Collimator is the first listed.
NCT02455219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02455219 about?
NCT02455219 is a clinical study titled "DatScan With Prototype Collimator". A collimator is an accessory to a SPECT/CT scanner. It can be compared to a camera lens or filter that enhances or improves photos. The prototype collimators are able to magnify target organs about four times compared to the current collimators. In this study we are validating a new collimator desig...
What is the current status of trial NCT02455219?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-06. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02455219?
The interventions under investigation include: Prototype UHRSZ (UltraHigh Resolution Smart Zoom) Collimator (DEVICE).
Who is sponsoring clinical trial NCT02455219?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia